PR
Padmini Ramachandran
About Padmini Ramachandran
Data last updated:
Padmini Ramachandran is a Director at Toxiven Biotech Private Limited (since 2024). The company operates in Life Sciences. Toxiven Biotech Private Limited reported revenue of ₹1.74 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Toxiven Biotech Private Limited U24304TZ2019PTC031781 | Director | 25 Nov 2024 | 2019 | ₹1.74 Cr (FY 2025) | Active |
Board colleagues of Padmini Ramachandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arumugam Sundhararajan | 10392029 | Toxiven Biotech Private Limited | Director |
| Harry Fonseca Williams | 08394353 | Toxiven Biotech Private Limited | Director |
| Mohanraj Vaiyapuri | 10827704 | Toxiven Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Padmini Ramachandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Padmini Ramachandran
Padmini Ramachandran currently holds 1 directorship: Toxiven Biotech Private Limited (Director, since 25 Nov 2024, revenue ₹1.74 Cr (FY 2025)).
Padmini Ramachandran was first appointed on 25 Nov 2024 as Director at Toxiven Biotech Private Limited.
The current boards of Padmini Ramachandran's companies include Arumugam Sundhararajan (Toxiven Biotech Private Limited), Harry Fonseca Williams (Toxiven Biotech Private Limited), Mohanraj Vaiyapuri (Toxiven Biotech Private Limited).